1st Quarter - Report
INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH
Client
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 933, Consolidated and Further Continuing Appropriations Act of 2013, monitored development of final legislation. H.R. ______, Department of Defense Appropriations Act, 2014, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID FREDERICK KILIAN | — |
| STACY LADWIG | — |
| JOHN LITTLE | — |
| STEPHEN SEMLER | — |
| LETITIA WHITE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.